Schöffski, P <br/><br/>
Clinical phase II study and pharmacological evaluation of rubitecan in non-pretreated patients with metastatic colorectal cancer-significant effect of food intake on the bioavailability of the oral camptothecin analogue.  [electronic resource] 

 -  European journal of cancer (Oxford, England : 1990)  Apr 2002 
 - 807-13 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0959-8049 
<br/><br/><label>Standard No.: </label>10.1016/s0959-8049(02)00022-9  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Adult<br/>Aged<br/>Antineoplastic Agents--therapeutic use<br/>Antineoplastic Agents, Phytogenic--administration & dosage<br/>Biological Availability<br/>Camptothecin--administration & dosage<br/>Colorectal Neoplasms--drug therapy<br/>Cross-Over Studies<br/>Eating--physiology<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>Neoplasm Metastasis